Tuesday, April 27, 2010

FDA warns TEVA

The Food and Drug Administration said it found "significant" manufacturing violations at Teva Pharmaceutical Industries Ltd. (TEVA) facility that makes the sedative drug propofol.

The agency posted a Dec. 11 warning letter to its Web site on Tuesday. The letter involved violations found during a FDA inspection of an Irvine, Calif. facility last July. Propofol, an injectable drug, is used for general anesthesia or sedation in operating rooms and intensive care units.

Source here.

Reblog this post [with Zemanta]